Vitamin K2 directs calcium to the right places in your body. It activates proteins that pull calcium into bones and teeth while keeping it out of your arteries, kidneys, and other soft tissues where it can cause harm. This makes it distinct from vitamin K1, which primarily handles blood clotting. Most people get plenty of K1 from leafy greens but far less K2, which comes mainly from fermented and animal-based foods.
How K2 Controls Calcium in Your Body
Vitamin K2 works by switching on specific proteins that would otherwise sit idle. Two of the most important are osteocalcin, which operates in bones, and matrix Gla protein (MGP), which operates in blood vessels. Both proteins need K2 to become “activated” through a chemical process called carboxylation. Without enough K2, these proteins remain in their inactive form and can’t do their jobs.
Osteocalcin, once activated, binds calcium and helps deposit it into bone tissue. Matrix Gla protein does roughly the opposite: it binds calcium crystals in artery walls, blocks their growth, and prevents the smooth muscle cells lining blood vessels from transforming into bone-like cells. MGP also neutralizes a signaling molecule called BMP-2 that would otherwise promote mineralization in soft tissue. When vitamin K is deficient in the vascular wall, inactive MGP accumulates and calcium deposits go unchecked.
Think of K2 as a traffic controller. It doesn’t increase or decrease the total amount of calcium in your bloodstream. Instead, it ensures calcium ends up in bone rather than lodging in your arteries.
K2 and Heart Health
Arterial calcification, the buildup of calcium in blood vessel walls, is a well-established risk factor for heart disease. Because K2 activates the protein that prevents this buildup, researchers have spent years studying whether higher K2 intake translates to better cardiovascular outcomes. The evidence is compelling, especially from large population studies.
In the prospective Rotterdam Study, people with the highest vitamin K2 intake had roughly half the risk of severe aortic calcification compared to those with the lowest intake, and their cardiovascular mortality risk was 57% lower. A Norwegian study following nearly 3,000 healthy people for a median of 11 years found that those in the highest K2 intake group had about half the risk of coronary artery disease. Another large cohort study found that each additional 10 micrograms per day of K2 was associated with a 10% reduction in coronary artery disease risk. Notably, these associations held for K2 but not for K1.
A meta-analysis pooling data across studies found that higher K2 consumption was associated with a 30% lower risk of coronary artery disease. Supplementation trials have also shown improvements in arterial stiffness, a measure of how flexible your blood vessels are, in healthy adults, postmenopausal women, and people with existing heart disease. A review in BMJ Open Heart noted that the effective dose of longer-chain forms of K2 (like MK-7) for cardiovascular benefits falls in the range of 180 to 360 micrograms per day.
K2 and Bone Strength
The bone story is more nuanced. K2 clearly activates osteocalcin, the protein responsible for binding calcium into bone. Supplementation consistently improves osteocalcin carboxylation, meaning more of this protein shifts from its inactive to its active form. But whether that biochemical change reliably increases bone mineral density or prevents fractures is still debated.
Some Japanese studies using pharmacologic doses of MK-4 (a short-chain form of K2) showed reduced fracture rates. A three-year trial found that 180 micrograms per day of MK-7 slowed age-related bone loss. But other well-designed trials, particularly in North American and European populations, found no significant effect on bone density or fracture risk. One three-year trial using 375 micrograms per day of MK-7 improved osteocalcin activation but didn’t change bone density or bone structure.
The takeaway: K2 reliably improves the biochemical markers of bone health, but the clinical payoff in terms of stronger bones and fewer fractures likely depends on your baseline vitamin K status, the dose and form used, and other factors like calcium and vitamin D intake.
How K2 Works With Vitamin D
Vitamin D increases calcium absorption from your gut, which is essential for bone health. But more calcium in the bloodstream isn’t automatically beneficial. It needs to be directed into bone, not deposited in arteries. That’s where K2 comes in. Vitamin D raises the supply of calcium; K2 activates the proteins that route it correctly.
Taking vitamin K2 alongside vitamin D may be safer than taking vitamin D alone, particularly at higher doses, because K2 helps prevent the excess calcium from accumulating in soft tissues. If you supplement with vitamin D, pairing it with K2 supports the full pathway from absorption to proper deposition.
How K2 Differs From K1
Vitamin K1 (phylloquinone) and vitamin K2 (menaquinones) belong to the same vitamin family but behave differently in the body. K1 is the main dietary form, found abundantly in green vegetables like spinach, kale, and broccoli. It goes primarily to the liver, where it supports the production of blood-clotting proteins.
K2 exists in several subtypes, labeled MK-4 through MK-13, based on the length of their molecular side chains. These forms are distributed more broadly to tissues outside the liver, including bone, cartilage, and blood vessels. Your body can convert a small amount of K1 into MK-4, but this conversion is limited. The longer-chain forms like MK-7 must come from food or supplements. Longer-chain forms also stay in the bloodstream longer, which is why MK-7 is the most popular supplemental form.
MK-4 vs. MK-7
The two most studied forms of K2 are MK-4 and MK-7, and they differ in practical ways. MK-4 has a short half-life in the blood, meaning it’s cleared quickly and typically needs to be taken multiple times a day or in large doses to maintain levels. MK-7 has a longer half-life, so a single daily dose maintains more stable blood levels throughout the day.
MK-4 is found naturally in animal products like chicken, eggs, and butter. It’s also the form your body produces by converting K1. MK-7 comes primarily from bacterial fermentation, with natto (fermented soybeans) being by far the richest source. Most supplement research on cardiovascular and bone health has focused on MK-7 because of its longer-lasting presence in the blood and its effectiveness at lower doses.
Best Food Sources of K2
Vitamin K2 content in food varies because it depends on bacterial activity during production or in the animal’s gut. Still, certain foods are consistently rich sources:
- Natto (fermented soybeans): The single richest source, providing roughly 850 micrograms of MK-7 per 3-ounce serving. Nothing else comes close.
- Hard and aged cheeses: Gouda, cheddar, and blue cheese contain meaningful amounts, primarily as MK-4. Cheddar provides about 4 micrograms per 1.5-ounce serving.
- Egg yolks: About 4 micrograms of MK-4 per large egg.
- Chicken (especially dark meat and liver): Chicken breast provides about 13 micrograms of MK-4 per 3-ounce serving; liver provides about 6 micrograms.
- Ground beef: Around 6 micrograms of MK-4 per 3-ounce serving.
- Butter and fermented dairy: Butter and kefir contain smaller but consistent amounts.
- Sauerkraut: A plant-based option with modest K2 from bacterial fermentation.
Unless you eat natto regularly, it’s difficult to reach the 180 to 360 microgram range associated with cardiovascular benefits from food alone. Most Western diets provide relatively little K2, which is one reason supplementation has gained attention.
The Warfarin Interaction
If you take warfarin or another coumarin-based blood thinner, vitamin K2 requires serious caution. Warfarin works by blocking the recycling of vitamin K in the liver, which reduces the production of clotting factors. Any increase in vitamin K intake, whether from food or supplements, can partially override warfarin’s effect and reduce its ability to prevent clots.
This isn’t limited to K1. K2 uses the same enzymatic pathway and can interfere with warfarin in the same way. People on warfarin are advised to keep their vitamin K intake consistent from day to day rather than swinging between high and low amounts, because fluctuations make dosing unpredictable. Large doses of vitamin K (above 5 milligrams) can make a person resistant to warfarin for up to a week. If you’re on warfarin and considering K2 supplementation, this is a conversation to have with whoever manages your anticoagulation therapy.
Newer blood thinners that work through different mechanisms don’t share this interaction. One study found that switching from warfarin to a newer anticoagulant dramatically reduced markers of vitamin K deficiency, with inactive prothrombin dropping from 100% to 2% of patients, and this was accompanied by measurable improvements in arterial stiffness.